Actylis
Actylis is a B2B specialty ingredients manufacturer and distributor supplying vitamins, minerals, supplements, pharmaceutical excipients, and specialty solvents to pharmaceutical, nutrition, and industrial chemical manufacturers across North America.
- Company typePrivate
- Founded2022
- HeadquartersPort Washington, United States
- Headcount501–1,000
- GTM typeB2B
- OfferingHardware or Manufacturing
What Actylis does
Actylis is a privately held specialty ingredients manufacturer and distributor serving the life sciences, pharmaceutical, nutrition, and specialty chemical industries. Founded in 2022 and headquartered in New York, the company supplies vitamins, minerals, supplements, pharmaceutical excipients, and specialty solvents to B2B customers including dietary supplement manufacturers, OTC and prescription pharmaceutical producers, and industrial chemical users across North America. Its product portfolio includes acquired brands such as Pharm-RX (acquired October 2024) and specialty solvent distribution such as PCBTF (partnered with Aarti Industries in February 2026). Actylis also previously operated an API manufacturing facility in Eugene, Oregon (legacy Cascade Chemistry), which was divested to Agno Pharma in January 2026, indicating a strategic refocus toward distribution and specialty ingredient consolidation rather than upstream API production.
The company's go-to-market is sales-led B2B, relying on direct enterprise relationships with manufacturers and quote-based pricing on bulk orders and contracts. Its core technology is supply chain and distribution orchestration rather than proprietary software or AI; competitive positioning rests on portfolio breadth built through acquisitions (notably Pharm-RX) and distribution partnerships that combine manufacturing partners' capacity with Actylis's regional North American reach. The company employs 501–1,000 people and serves the fragmented specialty ingredients supply chain by acting as a consolidating single-source platform, addressing manufacturer pain points around supply security, regulatory compliance for pharma-grade ingredients, and access to a broad specialty ingredient catalog.
Actylis firmographics
Firmographics- Name
- Actylis
- Website
- https://actylis.com
- Company type
- Private
- Founded year
- 2022
- Operating status
- Operating
- Headcount range
- 501–1,000 employees
- Short description
- Actylis is a B2B specialty ingredients manufacturer and distributor supplying vitamins, minerals, supplements, pharmaceutical excipients, and specialty solvents to pharmaceutical, nutrition, and industrial chemical manufacturers across North America.
- Ownership category
- akta.pro rank
Actylis industry classification
Industry- Product category
- Specialty Ingredients Manufacturing and Distribution
- NAICS
- Chemical and Allied Products Merchant Wholesalers (4246), Drugs and Druggists' Sundries Merchant Wholesalers (424210), Medicinal and Botanical Manufacturing (325411)
- SIC
- Wholesale-Chemicals & Allied Products (5160), Medicinal Chemicals & Botanical Products (2833), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)
- akta.pro primary industry
- Specialty Pharmaceutical Distributors (HLAIAJAB)
- akta.pro secondary industries
- Compounding Ingredient & API Distributors (Pharma Supply) (HLAIAJAO), Personal Care & Cosmetic Ingredients (IMAEABAJ), Food-Grade Additives & Functional Ingredients Trading/Wholesale (AFAIAKAI), Chemicals, Ingredients & Raw Materials Marketplaces (CRAFAHAK)
Keywords
Where Actylis is headquartered
LocationHeadquarters
- HQ city
- Port Washington
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
Actylis business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Personnel, Marketing or Sales, Technology or R&D
Revenue model
- Specialty Ingredients Sales: Actylis generates revenue through the sale and distribution of specialty ingredients to pharmaceutical, vitamin, mineral, and supplement manufacturers. The company serves as a provider of raw materials and ingredients for the life sciences industry.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels1 record
Actylis product offering
Product offeringCore offering
Actylis manufactures and distributes specialty raw materials and ingredients—including vitamins, minerals, dietary supplements, pharmaceutical excipients, active pharmaceutical ingredients (APIs), and specialty solvents—for biopharma, cosmetics, chemicals, nutrition, and agriscience manufacturers. The company serves as a B2B ingredient supplier, combining acquired product portfolios (e.g., Pharm-RX) with channel distribution partnerships (e.g., Aarti Industries for PCBTF solvent) to provide manufacturers with a consolidated source for formulation and production inputs.
Product overview
Actylis is a life sciences and specialty ingredients provider based in NYC. The company operates as a specialty ingredients supplier serving the vitamin, mineral, supplement, pharmaceutical, and nutrition markets. Actylis' portfolio includes acquired brands like Pharm-Rx and specialty chemical distribution services such as PCBTF solvent. The company focuses on expanding its solutions through strategic acquisitions and distribution partnerships to enhance its product portfolio and accelerate growth in nutrition and OTC pharmaceutical markets.
Differentiator
Problem solved
Functional benefit
Products and services
- Pharm-RX Specialty Ingredients
- PCBTF Solvent Distribution
Companies that use Actylis
Customer profileSegments3 records
Ideal customer profiles3 records
Actylis technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Actylis partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Aarti Industries LimitedcoreActylis has partnered with Aarti Industries Limited to distribute PCBTF solvent across North America. This collaboration combines Aarti's manufacturing capabilities with Actylis's regional distribution network to enhance supply security and market reach for industrial and specialty applications. The partnership aims to support customers requiring specialty solvents with reliable supply and distribution services.
Scale indicators1 record
Recent moves5 records
Expansion highlights4 records
Actylis competitors and assessment
Company assessmentDirect peers
- IMCD: Specialty chemicals and ingredients distributor with a strong focus on life sciences, personal care, food, and pharma — highly comparable value proposition and customer mix to Actylis.
- Azelis: Global specialty ingredients distributor serving pharma, personal care, food, and industrial markets with a partnership- and acquisition-led growth model similar to Actylis's stated roll-up approach.
- Hawkins: Specialty chemical distributor serving industrial, water treatment, and pharma/food customers with a regional distribution focus. Similar mid-sized B2B distribution profile to Actylis.
- Barentz: Specialty ingredients distributor focused on life sciences, personal care, and food markets, with an active acquisition strategy (including the Maroon Group acquisition). Comparable business model and customer base to Actylis.
- Spectrum Chemical: Specialty chemical and ingredient supplier serving pharmaceutical, nutraceutical, and laboratory customers. Comparable focus on regulated, high-quality ingredients distributed to manufacturers.
- Univar Solutions: One of the largest North American specialty chemical and ingredient distributors, serving pharma, food, personal care, and industrial end-markets. Direct overlap with Actylis's specialty ingredients distribution model and B2B sales-led GTM.
- Brenntag: Global market leader in chemical and ingredients distribution with deep pharma, nutrition, personal care, and industrial portfolios. Closely comparable to Actylis across verticals and customer types.
Broad incumbents
- Arxada: Global specialty chemicals business serving microbial control, personal care, and industrial markets. Broader portfolio than Actylis, but comparable B2B specialty ingredients distribution into regulated end-markets.
- Ingredion: Large global ingredient solutions provider for food, beverage, and personal care. Broader and more food-centric than Actylis, but overlapping in ingredient distribution to manufacturers and nutrition customers.
- Innophos: Specialty ingredient manufacturer and supplier for pharma, health, nutrition, and industrial markets. Comparable product overlap in excipients and specialty minerals, though more manufacturing-anchored than Actylis's distribution-led model.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
Actylis social profiles
Digital presenceActylis financial estimates
Financial estimateRevenue estimate
Valuation estimate
Actylis leadership team
Management profileNumber of profiles
Profiles3 records
Actylis subsidiaries and ownership
Company hierarchySubsidiaries1 record
Actylis funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Actylis M&A and investment
M&A and investmentM&A1 record
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Actylis
What does Actylis do?
Actylis manufactures and distributes specialty raw materials and ingredients—including vitamins, minerals, dietary supplements, pharmaceutical excipients, active pharmaceutical ingredients (APIs), and specialty solvents—for biopharma, cosmetics, chemicals, nutrition, and agriscience manufacturers. The company serves as a B2B ingredient supplier, combining acquired product portfolios (e.g., Pharm-RX) with channel distribution partnerships (e.g., Aarti Industries for PCBTF solvent) to provide manufacturers with a consolidated source for formulation and production inputs.
Is Actylis a public or private company?
Actylis is a private company. It is classified as unknown and is currently operating.
When was Actylis founded?
Actylis was founded in 2022. It employs 501 to 1,000 people.
Where is Actylis based?
Actylis is headquartered in Port Washington, United States, in the North America region.
How does Actylis make money?
One revenue line is on record: specialty Ingredients Sales.
Who are Actylis's main competitors?
Direct peers on record are IMCD, Azelis, Hawkins, Barentz, Spectrum Chemical, Univar Solutions and Brenntag. Broad incumbents are Arxada, Ingredion and Innophos.
Does Actylis have an API?
No public API is recorded for Actylis.
What industry is Actylis in?
Actylis's product category is Specialty Ingredients Manufacturing and Distribution. Its primary akta.pro industry code is HLAIAJAB, Specialty Pharmaceutical Distributors, with a secondary code of HLAIAJAO, Compounding Ingredient & API Distributors (Pharma Supply). Its NAICS code is 4246 and its SIC code is 5160.